Posted on July 8, 2009 by Patients and Patents
The World Health Organization reports that a clinical trial is being launched in three African countries of a drug that could eliminate onchocerciasis, or river blindness, one of the leading infectious causes of blindness across Africa. The drug, moxidectin, is being investigated for its potential to kill or sterilize the adult worms of Onchocerca volvulus, [...]
Filed under: Africa, Public health, World Health Organization | Tagged: Innovation, neglected diseases, World Health Organization | Leave a Comment »
Posted on March 26, 2009 by Patients and Patents
The World Health Organization released its’ thirteenth report on Tuberculosis control this week, which provides information and statistics related to the numbers of cases and numbers of deaths due to TB in 196 countries. The report stresses the link between HIV and TB, suggesting that roughly 25% of people who died from TB in 2007 were [...]
Filed under: Public health | Tagged: neglected diseases, Public health, tuberculosis, World Health Organization | 1 Comment »
Posted on March 20, 2009 by Patients and Patents
Tuberculosis, the world’s second deadliest infectious disease could finally meet its match in a new vaccine developed by researchers at McMaster University. The new vaccine is at least five years away from broad use, if it can be shown to be safe, effective and practical to make and distribute — and if another team doesn’t [...]
Filed under: North America, Public health | Tagged: Innovation, neglected diseases, research and development, tuberculosis | Leave a Comment »
Posted on February 3, 2009 by Patients and Patents
The Global Network for Neglected Tropical Diseases recently announced that it has received $34 million through a grant from the Bill & Melinda Gates Foundation to the Sabin Vaccine Institute to step up the global effort to prevent and treat neglected tropical diseases (NTDs). These debilitating and sometimes deadly diseases affect 1.4 billion people worldwide [...]
Filed under: Public health | Tagged: access to medicines, neglected diseases | Leave a Comment »
Posted on January 8, 2009 by Patients and Patents
One of the many topics that have been discussed in the wake of the WHO’s intergovernmental working group on public health, innovation and intellectual property, is the issue of incentives for research into neglected tropical diseases. Over the past decade, many public-private partnerships, government programs and other initiatives have fostered medical research into diseases primarily affecting developping countries [...]
Filed under: IGWG, Public health | Tagged: Innovation, neglected diseases, World Health Organization | Leave a Comment »
Innovative vaccine venture offers hope to less-developed countries
Britain’s largest charity, the Wellcome Trust, and pharmaceutical company Merck & Co. have joined together to create a non-profit, £90-million (about $150 million) research center in India to facilitate the development of new vaccines, “including [those for] neglected diseases for which inadequate or no vaccines exist.” According to Nature News, “the move marks the first [...]
Filed under: Commentary on news & events, Innovation | Tagged: access to medicines, drug development, least-developed countries, neglected diseases, vaccine | 2 Comments »